| Literature DB >> 26666403 |
Athanasia K Papazafiropoulou1, Florentia Bakomitrou2, Aikaterini Trikallinou3, Asimina Ganotopoulou4, Chris Verras5, George Christofilidis6, Stavros Bousboulas7, Αndreas Μelidonis8.
Abstract
BACKGROUND: Diabetes mellitus type 2 (T2D) is a chronic metabolic disease with a great impact on health status and quality of life (QoL) in terms of physical, social, and psychological well-being. The aim of the present study was to measure diabetes-dependent QoL and affecting factors in patients with T2D.Entities:
Mesh:
Year: 2015 PMID: 26666403 PMCID: PMC4678457 DOI: 10.1186/s13104-015-1782-8
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Demographic and clinical characteristics of the study population
| Variables | N (%) |
|---|---|
| Gender (males) | 131 (51.8) |
| Age ± SD (years) | 58.1 ± 11.1 |
| Diabetes duration ± SD (years) | 10.3 ± 3.8 |
| HbA1c ± SD (%) | 7.1 ± 1.4 |
| Body mass index ± SD (kg/m2) | 31.5 ± 7.1 |
| Monthly income (Euros) | |
| ≤700 | 130 (50.7) |
| 700–1000 | 52 (20.3) |
| ≥3000 | 76 (29.0) |
| Educational level | |
| Low | 75 (29.3) |
| High | 183 (70.7) |
| Marital status | |
| Never married | 36 (14.3) |
| Married | 211 (82.7) |
| Divorced | 11 (4.0) |
| Smoking status | |
| Non or ex smoker | 162 (63.4) |
| Current smoker | 96 (36.6) |
| Oral antidiabetic therapy (yes) | 199 (77.5) |
| Insulin therapy (yes) | 115 (44.8) |
| Coronary artery disease (yes) | 36 (14.2) |
| Cerebrovascular disease (yes) | 10 (4.0) |
| Peripheral arterial disease (yes) | 11 (4.5) |
| Retinopathy (yes) | 25 (9.5) |
| Neuropathy (yes) | 13 (4.9) |
| Chronic kidney disease (yes) | 12 (4.6) |
Distribution of response by impact and importance rating together with weighted impact score
| Domain | Impact rating | Mean ± SD importance rating | Weighted impact score |
|---|---|---|---|
| Leisure activities | −1.1 ± 1.0 | 1.9 ± 0.8 | −2.3 ± 2.6 |
| Working life | −1.3 ± 1.0 | 2.2 ± 0.9 | −2.9 ± 2.9 |
| Journeys | −1.1 ± 0.2 | 1.8 ± 0.9 | −2.4 ± 2.7 |
| Holidays | −1.2 ± 1.1 | 1.8 ± 0.9 | −2.4 ± 2.7 |
| Physical health | −1.3 ± 1.0 | 2.0 ± 0.8 | −2.8 ± 2.9 |
| Family life | −1.3 ± 1.0 | 2.6 ± 0.8 | −3.2 ± 3.1 |
| Friendship and social life | −1.1 ± 1.1 | 2.3 ± 0.8 | −2.4 ± 2.9 |
| Personal relationship | −1.2 ± 1.2 | 2.2 ± 0.9 | −2.6 ± 3.2 |
| Sex life | −1.3 ± 1.1 | 2.1 ± 0.9 | −2.8 ± 3.2 |
| Physical appearance | −1.0 ± 1.1 | 1.9 ± 0.8 | −2.0 ± 2.8 |
| Self-confidence | −1.2 ± 1.1 | 2.3 ± 0.8 | −2.9 ± 3.1 |
| Motivation | −1.0 ± 1.1 | 2.3 ± 0.8 | −2.7 ± 3.1 |
| People’s reaction | −1.0 ± 1.0 | 2.1 ± 0.8 | −1.6 ± 2.4 |
| Feelings about future | −1.3 ± 1.3 | 2.3 ± 0.7 | −3.2 ± 4.1 |
| Financial situation | −1.0 ± 1.3 | 2.2 ± 0.8 | −2.2 ± 3.8 |
| Living conditions | −1.3 ± 1.1 | 2.3 ± 0.7 | −3.0 ± 3.1 |
| Dependence on others | −1.0 ± 1.0 | 2.4 ± 0.8 | −2.5 ± 3.0 |
| Freedom to eat | −1.7 ± 1.0 | 2.1 ± 0.9 | −4.2 ± 3.2 |
| Freedom to drink | −1.3 ± 1.9 | 1.5 ± 1.1 | −2.5 ± 2.9 |
Impact rating (conditions without diabetes): −3, very much better; −2, much better; −1, a little better; 0, the same; +1, worse
Importance rating: 0, not at all important; 1, somewhat important; 2, important; 3, very important
Weighted impact score ¼ impact rating (−3 to +1) × importance rating (0–3) ¼ −9 (maximum negative impact of diabetes) to +3 (maximum positive impact of diabetes)
Logistic regression analysis: predictors of lower QOL according to the ADDQOL score
| Variables | Odds ratio | 95 % confidence intervals | P value |
|---|---|---|---|
| Gender (males) | 1.09 | 0.49–2.46 | 0.82 |
| Age (years) |
|
|
|
| Diabetes duration (years) | 0.96 | 0.92–0.98 | 0.24 |
| HbA1c (%) | 0.91 | 0.74–1.31 | 0.91 |
| Body mass index (kg/m2) | 0.98 | 0.93–1.04 | 0.49 |
| Monthly income (Euros) | 2.61 | 0.86–7.89 | 0.09 |
| Educational level | 1.42 | 0.65–3.14 | 0.38 |
| Marital status |
|
|
|
| Smoking status | 0.53 | 0.22–1.24 | 0.14 |
| Oral antidiabetic therapy (yes) | 0.86 | 0.28–2.65 | 0.81 |
| Insulin therapy (yes) | 0.26 | 0.22–1.49 | 0.26 |
| Coronary artery disease (yes) | 0.73 | 0.24–2.24 | 0.58 |
| Cerebrovascular disease (yes) | 0.08 | 0.22–1.98 | 0.48 |
| Peripheral arterial disease (yes) | 0.32 | 0.45–1.81 | 0.19 |
| Retinopathy (yes) | 0.14 | 0.01–1.36 | 0.09 |
| Neuropathy (yes) | 0.26 | 0.02–2.26 | 0.21 |
| Chronic kidney disease (yes) | 0.12 | 0.12–1.23 | 0.10 |